Establishment Labs Holdings (ESTA) Non Operating Interest Expenses (2017 - 2026)
Establishment Labs Holdings (ESTA) posted Non Operating Interest Expenses of $7.0 million for Q2 2026, down 0.76% on a QoQ basis from $7.1 million in Q1 2026, and up 18.1% year-over-year from $6.0 million in Q2 2025.
Analysis
Establishment Labs Holdings (ESTA) Non Operating Interest Expenses (2017 - 2026) Analysis & Trends
Establishment Labs Holdings has reported Non Operating Interest Expenses for 10 years, with the latest figure at $7.0 million in Q2 2026.
- On a quarterly basis, Non Operating Interest Expenses rose 18.1% year-over-year to $7.0 million in Q2 2026; TTM through Jun 2026 was $27.6 million, a 19.5% increase from a year earlier, with the FY2025 full-year figure at $25.3 million, up 21.25% from the prior year.
- Non Operating Interest Expenses was $7.0 million for Q2 2026 at Establishment Labs Holdings, down from $7.1 million in the prior quarter.
- The five-year high for Non Operating Interest Expenses was $7.2 million in Q4 2025, with the low at $2.2 million in Q4 2022.
- Average Non Operating Interest Expenses over 5 years is $4.9 million, with a median of $4.8 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses declined 5.42% in 2022, then soared 97.18% in 2023.
- Over 5 years, Non Operating Interest Expenses stood at $2.2 million in 2022, then jumped by 97.18% to $4.3 million in 2023, then jumped by 37.14% to $5.9 million in 2024, then gained by 21.77% to $7.2 million in 2025, then decreased by 2.9% to $7.0 million in 2026.
- The last three Non Operating Interest Expenses figures came in at $7.0 million (Q2 2026), $7.1 million (Q1 2026), and $7.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.13 Bn | 178.52 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 124.47 Bn | 119.25 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.42 Bn | 109.60 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 106.29 Bn | 102.82 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.72 Bn | 66.18 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.99 Bn | 32.53 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.15 Bn | 30.21 Bn | 830.00 Mn | - |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Establishment Labs Holdings | 2.25 Bn | 2.18 Bn | 47.71 Mn | 7.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.03 Mn |
| Mar 31, 2026 | 7.09 Mn |
| Dec 31, 2025 | 7.24 Mn |
| Sep 30, 2025 | 6.20 Mn |
| Jun 30, 2025 | 5.96 Mn |
| Mar 31, 2025 | 5.85 Mn |
| Dec 31, 2024 | 5.95 Mn |
| Sep 30, 2024 | 5.31 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Mar 31, 2024 | 4.38 Mn |
| Dec 31, 2023 | 4.34 Mn |
| Sep 30, 2023 | 3.68 Mn |
| Jun 30, 2023 | 3.62 Mn |
| Mar 31, 2023 | 3.76 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 3.88 Mn |
| Jun 30, 2022 | 3.39 Mn |
| Mar 31, 2022 | 2.29 Mn |
| Dec 31, 2021 | 2.33 Mn |
| Sep 30, 2021 | 2.29 Mn |